420 related articles for article (PubMed ID: 17573884)
1. Fabry disease and the skin: data from FOS, the Fabry outcome survey.
Orteu CH; Jansen T; Lidove O; Jaussaud R; Hughes DA; Pintos-Morell G; Ramaswami U; Parini R; Sunder-Plassman G; Beck M; Mehta AB;
Br J Dermatol; 2007 Aug; 157(2):331-7. PubMed ID: 17573884
[TBL] [Abstract][Full Text] [Related]
2. [Fabry disease: demographic data since introduction of enzyme replacement therapy].
Cybulla M; Walter K; Neumann HP; Widmer U; Schärer M; Sunder-Plassmann G; Jansen T; Rolfs A; Beck M
Dtsch Med Wochenschr; 2007 Jul; 132(28-29):1505-9. PubMed ID: 17607649
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of patients with Fabry disease in Argentina].
AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales)
Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022
[TBL] [Abstract][Full Text] [Related]
4. Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey.
Sodi A; Ioannidis AS; Mehta A; Davey C; Beck M; Pitz S
Br J Ophthalmol; 2007 Feb; 91(2):210-4. PubMed ID: 16973664
[TBL] [Abstract][Full Text] [Related]
5. Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients.
Navarro C; Teijeira S; Dominguez C; Fernandez JM; Rivas E; Fachal C; Barrera S; Rodriguez C; Iranzo P
Acta Neuropathol; 2006 Feb; 111(2):178-85. PubMed ID: 16463201
[TBL] [Abstract][Full Text] [Related]
6. Fabry disease in Spain: description of Spanish patients and a comparison with other European countries using data from the Fabry Outcome Survey (FOS).
Barba-Romero MÁ; Rivera-Gallego A; Pintos-Morell G;
Int J Clin Pract; 2011 Aug; 65(8):903-10. PubMed ID: 21679285
[TBL] [Abstract][Full Text] [Related]
7. Hyperhidrosis: a new and often early symptom in Fabry disease. International experience and data from the Fabry Outcome Survey.
Lidove O; Ramaswami U; Jaussaud R; Barbey F; Maisonobe T; Caillaud C; Beck M; Sunder-Plassmann G; Linhart A; Mehta A;
Int J Clin Pract; 2006 Sep; 60(9):1053-9. PubMed ID: 16939546
[TBL] [Abstract][Full Text] [Related]
8. Angiokeratoma: decision-making aid for the diagnosis of Fabry disease.
Zampetti A; Orteu CH; Antuzzi D; Bongiorno MR; Manco S; Gnarra M; Morrone A; Cardinali G; Kovacs D; Aspite N; Linder D; Parini R; Feliciani C;
Br J Dermatol; 2012 Apr; 166(4):712-20. PubMed ID: 22452439
[TBL] [Abstract][Full Text] [Related]
9. Renal involvement in Anderson-Fabry disease.
Sessa A; Meroni M; Battini G; Righetti M; Maglio A; Tosoni A; Nebuloni M; Vago G; Giordano F
J Nephrol; 2003; 16(2):310-3. PubMed ID: 12774774
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous complications of Anderson-Fabry disease.
Giuseppe P; Daniele R; Rita BM
Curr Pharm Des; 2013; 19(33):6031-6. PubMed ID: 23448454
[TBL] [Abstract][Full Text] [Related]
11. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy.
Ortiz A; Oliveira JP; Waldek S; Warnock DG; Cianciaruso B; Wanner C;
Nephrol Dial Transplant; 2008 May; 23(5):1600-7. PubMed ID: 18175781
[TBL] [Abstract][Full Text] [Related]
12. Nailfold capillaroscopy: Specific features in Fabry disease.
Wasik JS; Simon RW; Meier T; Steinmann B; Amann-Vesti BR
Clin Hemorheol Microcirc; 2009; 42(2):99-106. PubMed ID: 19433883
[TBL] [Abstract][Full Text] [Related]
13. Disease manifestations and X inactivation in heterozygous females with Fabry disease.
Maier EM; Osterrieder S; Whybra C; Ries M; Gal A; Beck M; Roscher AA; Muntau AC
Acta Paediatr Suppl; 2006 Apr; 95(451):30-8. PubMed ID: 16720462
[TBL] [Abstract][Full Text] [Related]
14. Clinical spectrum of Anderson Fabry disease in a Romanian family.
Tudor A; Muşat A; Doscan A; Bari M; Zapucioiu C; Urdea E; Cochior D; Peţa D
Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300
[TBL] [Abstract][Full Text] [Related]
15. Late-onset Fabry disease associated with angiokeratoma of Fordyce and multiple cherry angiomas.
Hogarth V; Dhoat S; Mehta AB; Orteu CH
Clin Exp Dermatol; 2011 Jul; 36(5):506-8. PubMed ID: 21457158
[TBL] [Abstract][Full Text] [Related]
16. Fabry disease in hemodialysis patients in southern Brazil: prevalence study and clinical report.
Porsch DB; Nunes AC; Milani V; Rossato LB; Mattos CB; Tsao M; Netto C; Burin M; Pereira F; Matte U; Giugliani R; Barros EJ
Ren Fail; 2008; 30(9):825-30. PubMed ID: 18925518
[TBL] [Abstract][Full Text] [Related]
17. Anderson-Fabry disease: a multiorgan disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
[TBL] [Abstract][Full Text] [Related]
18. Hearing loss in Fabry disease: data from the Fabry Outcome Survey.
Hegemann S; Hajioff D; Conti G; Beck M; Sunder-Plassmann G; Widmer U; Mehta A; Keilmann A
Eur J Clin Invest; 2006 Sep; 36(9):654-62. PubMed ID: 16919049
[TBL] [Abstract][Full Text] [Related]
19. [Molecular pathology and clinical manifestations of Fabry disease].
Rákóczi E; Görögh S; Grubits J; Erdos M; Garzuly F; Hahn K; Bencsik K; Vécsei L; Trinn C; Kristóf E; Mogyorósy G; Tóth B; Maródi L
Orv Hetil; 2007 Jun; 148(23):1087-94. PubMed ID: 17545117
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of uncontrolled hypertension in patients with Fabry disease.
Kleinert J; Dehout F; Schwarting A; de Lorenzo AG; Ricci R; Kampmann C; Beck M; Ramaswami U; Linhart A; Gal A; Houge G; Widmer U; Mehta A; Sunder-Plassmann G
Am J Hypertens; 2006 Aug; 19(8):782-7. PubMed ID: 16876675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
